Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2010
05/13/2010US20100119550 Recombinant multivalent vaccine
05/13/2010US20100119548 Injecting directly into a tumor; cancer vaccine
05/13/2010US20100119523 Vascular endothelial cell growth factor antagonists
05/13/2010US20100119522 Combination therapy for the treatment of ocular neovascular disorders
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor
05/12/2010EP2184059A2 Ion binding polymers and uses thereof
05/12/2010EP2184055A1 Process for preparing solid dosage forms of rosiglitazone maleate
05/12/2010EP2182948A1 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
05/12/2010EP2182939A2 Compositions including triciribine and taxanes and methods of use thereof
05/12/2010EP2182810A2 Compositions and methods for treatment and prevention of osteoarthritis
05/12/2010EP1578772B1 Cytokines and cytokine receptors with reduced immunogenicity
05/12/2010EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
05/12/2010EP1519933B1 Quinuclidine amide derivatives
05/12/2010DE102008057230A1 Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin Synergistic pharmaceutical combination with an estrogen receptor antagonist and a progestin
05/12/2010CN1973832B Biodegradable nanometer medicine capsule with CT trace effect and its preparation process
05/12/2010CN1840193B Nanometer capsule of anthracene nucleus anticancer antibiotic with polyethylene glycol-phospholipid
05/12/2010CN1835735B Drug delivery system for administering fine particle under tenon's capsule
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1780616B Selective cytokine inhibitory drugs for treating disorders of the central nervous system
05/12/2010CN1764437B Topical pharmaceutical and/or cosmetic dispense systems
05/12/2010CN1642577B Preparation comprising buprenorphine
05/12/2010CN1617715B Treating muscle wasting with selective androgen receptor modulators
05/12/2010CN1599750B Cytotoxic protein and utilization thereof
05/12/2010CN1523985B Preparation of formulations of angiotensin IIAT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
05/12/2010CN101705287A Method for predicting the response to a treatment
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101703781A Magnetic medicament loading method for immunosuppressant
05/12/2010CN101703777A Tamper-resistant oral opioid agonist formulations
05/12/2010CN101703776A Method for preparing anti-infective agent long-acting injection
05/12/2010CN101703775A Medicinal composition for treating canker sore and local infection of body surface and reducing inflammation, product and application thereof
05/12/2010CN101703774A Pain killer with combination of opioids and aspartic acid acceptor antagonist and pain killing method
05/12/2010CN101703773A Novel analgetic combined by two clinically-applied drugs and analgesic method
05/12/2010CN101703761A Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/12/2010CN101703473A Polylactic acid-glycollic acid copolymer microspheres and preparation method
05/11/2010US7714183 the honey composition effects a change in the physical characteristics of the dressing; especially for chronic wound care
05/11/2010US7714139 IDO inhibitors and methods of use
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7713995 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
05/11/2010US7713984 Pharmaceutical uses
05/11/2010US7713957 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist
05/11/2010US7713949 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
05/11/2010US7713942 Drug delivery able crossing cellular membranes; transdermal, electrostatic interaction and a hydrophobic interaction
05/11/2010US7713930 Acidic insulin preparations having improved stability
05/11/2010US7713924 Methods for treating conditions associated with the accumulation of excess extracellular matrix
05/11/2010US7713554 Use of enhanced water to improve blood sugar management
05/11/2010US7713535 Respiratory disorders, inflammatory disorders, allergy, or asthma
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713523 Solubilized CoQ-10 and carnitine
05/11/2010CA2461958C Combination dosage form containing a cholesterol-lowering agent, a renin-angiotensin inhibitor, and aspirin
05/11/2010CA2442448C Condom with an erectogenic composition
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2274033C Biomaterial derived from vertebrate liver tissue
05/11/2010CA2223261C Improved delivery of diagnostic and therapeutic agents to a target site
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/06/2010WO2010051353A1 S1p lyase inhibitors for the treatment of cerebral malaria
05/06/2010WO2010051349A1 S1p receptor agonists for the treatement of cerebral malaria
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050422A1 Agent for treatment of diabetes
05/06/2010WO2010050328A1 Tumor metastasis inhibitor
05/06/2010WO2010050211A1 Composition for local anesthesia
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2010049709A2 Therapeutic compositions
05/06/2010WO2010049705A2 Therapeutic compositions
05/06/2010WO2010049078A1 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
05/06/2010WO2010048731A1 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents
05/06/2010WO2010048722A1 Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
05/06/2010WO2010048716A1 Composition and method for treating fibrosis
05/06/2010WO2010029089A3 Combination therapy for the treatment of diabetes and related conditions
05/06/2010WO2009151910A3 Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
05/06/2010WO2009145358A3 Medicament for the prophylaxis or treatment of hypertension
05/06/2010WO2009144719A3 Methods of killing cells and use of same in prevention and treatment of cancer
05/06/2010US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo)
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113607 Pharmaceutical Compositions
05/06/2010US20100113402 Compositions for treatment of inflammatory diseases
05/06/2010US20100113398 Treatment and/or Prevention of Non-Viral Epithelial Damage
05/06/2010US20100113396 Method and Composition for Potentiating an Opiate Analgesic
05/06/2010US20100113378 Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D
05/06/2010US20100112162 25-Hydroxy vitamin D3 compositions
05/06/2010US20100112091 Use of ramoplanin to treat diseases associated with the use of antibiotics
05/06/2010US20100112079 Thyroid Hormone Analogs and Methods of Use
05/06/2010US20100112027 Penis Enlargement
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
05/06/2010US20100111982 Rheumatoid arthritis t cell vaccine
05/06/2010US20100111942 Combination therapy for the treatment of ocular neovascular disorders
05/06/2010US20100111915 Probiotics for reduction of risk of obesity
05/06/2010US20100111913 Method of enhancing migration of neural precursor cells
05/06/2010US20100111912 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
05/06/2010US20100111835 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010CA2741954A1 Composition and method for treating fibrosis
05/06/2010CA2741838A1 S1p lyase inhibitors for the treatment of cerebral malaria
05/06/2010CA2741706A1 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
05/06/2010CA2741664A1 Method for selective control of helper t cell function
05/06/2010CA2741546A1 S1p receptor agonists for the treatement of cerebral malaria
05/06/2010CA2740058A1 An antidiabetic agent
05/05/2010EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 1151